ACCESSWIRE
09 May 2022, 21:37 GMT+10
MINNEAPOLIS, MN / ACCESSWIRE / May 9, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, today announced that it will release its financial results for the first quarter 2022 after the stock market close on Monday, May 16, 2022. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
Webcast and Conference Call Information
To participate in the teleconference, domestic callers should dial 1-844-825-9789 and international callers should dial 1-412-317-5180 and reference conference ID: 10166506. A live webcast presentation can also be accessed using this weblink: https://viavid.webcasts.com/starthere.jsp?ei=1545538&tp_key=5a345444e1. A replay of the webcast will be available on the Celcuity website following the live event.
About Celcuity
Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic and companion diagnostic strategy. The company's lead therapeutic candidate is gedatolisib, a potent, reversible dual inhibitor that selectively targets all Class I isoforms of PI3K and mTOR. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. The company expects to initiate a Phase 3 study evaluating gedatolisib in patients with HR+/HER2- advanced breast cancer in 2022. Its CELsignia companion diagnostic platform is uniquely able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from already approved targeted therapies. Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at www.celcuity.com.
Contacts:
Celcuity Inc.
Brian Sullivan, bsullivan@celcuity.com
Vicky Hahne, vhahne@celcuity.com
763-392-0123
ICR Westwicke
Robert Uhl, robert.uhl@westwicke.com
(619) 228-5886
SOURCE: Celcuity Inc.
Get a daily dose of Boston Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Boston Star.
More InformationNEW DELHI, India: Skyroot, India's first privately held company to design, build and test a solid rocket propulsion system, successfully ...
SYDNEY, NSW, Australia - Stocks in Asia were mostly moderately higher at the close Monday, while the U.S. dollar was ...
BEIJING, China: Chinese consumers have been vocal in their criticism of a $1,373 Gucci umbrella which should be kept out ...
STUTTGART, Germany: Beginning in 2025, Mercedes-Benz will incorporate a new, highly energy-dense battery in its G-Class electric vehicles, potentially solving ...
LONDON, England: UK prices are rising at their fastest rate in 40 years, as higher energy bills are changing spending ...
MINNEAPOLIS, Minnesota: Amidst the rising costs of essentials, such as fuel and food, and the rapid return by consumers to ...
After Marco Gonzales stymied the Toronto Blue Jays last week, allowing one run in six innings, Seattle Mariners manager Scott ...
One by-product of carrying the youngest roster in the majors is the occasional defensive lapse that proves costly, and for ...
Mumbai (Maharashtra) [India], May 23 (ANI): No case of Monkeypox has been reported in Mumbai so far, Brihanmumbai Municipal Corporation ...
Manny Machado had four extra-base hits in a game for the first time in his career and rookie left-hander MacKenzie ...
The Dallas Fuel and Atlanta Reign made big moves up the West division standings by feasting on bottom feeders Sunday ...
OpTic Texas stayed unbeaten in three matches and took sole possession of second place Sunday as Week 2 concluded in ...